Analysts Set Waldencast PLC (NASDAQ:WALD) PT at $4.42

Shares of Waldencast PLC (NASDAQ:WALDGet Free Report) have received a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $4.4167.

WALD has been the subject of a number of recent analyst reports. Canaccord Genuity Group decreased their price target on shares of Waldencast from $5.00 to $4.00 and set a “buy” rating for the company in a research report on Tuesday, November 25th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Waldencast in a research note on Wednesday, January 21st. Jefferies Financial Group began coverage on shares of Waldencast in a research report on Wednesday, January 14th. They issued a “buy” rating and a $2.00 target price for the company. Finally, Telsey Advisory Group lowered shares of Waldencast from an “outperform” rating to a “market perform” rating and set a $3.00 target price on the stock. in a research note on Tuesday, November 25th.

Read Our Latest Research Report on Waldencast

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in shares of Waldencast by 12.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 57,702 shares of the company’s stock valued at $114,000 after acquiring an additional 6,516 shares during the last quarter. Rhumbline Advisers boosted its holdings in Waldencast by 15.2% in the first quarter. Rhumbline Advisers now owns 61,630 shares of the company’s stock worth $185,000 after purchasing an additional 8,151 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Waldencast by 57.9% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,130 shares of the company’s stock valued at $57,000 after purchasing an additional 8,485 shares during the last quarter. Invesco Ltd. acquired a new stake in shares of Waldencast during the second quarter worth $26,000. Finally, Police & Firemen s Retirement System of New Jersey bought a new position in shares of Waldencast in the 2nd quarter worth about $26,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Waldencast Stock Up 0.6%

Shares of Waldencast stock opened at $1.75 on Thursday. Waldencast has a 1-year low of $1.45 and a 1-year high of $4.10. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.67 and a current ratio of 1.53. The business has a 50-day moving average of $2.01 and a 200-day moving average of $1.94.

Waldencast (NASDAQ:WALDGet Free Report) last issued its quarterly earnings results on Monday, November 24th. The company reported ($0.69) EPS for the quarter. The company had revenue of $66.14 million during the quarter. On average, sell-side analysts anticipate that Waldencast will post -0.14 EPS for the current year.

Waldencast Company Profile

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.

See Also

Analyst Recommendations for Waldencast (NASDAQ:WALD)

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.